Stay updated on CC-97540 in Severe SLE Clinical Trial
Sign up to get notified when there's something new on the CC-97540 in Severe SLE Clinical Trial page.
Latest updates to the CC-97540 in Severe SLE Clinical Trial page
- Check4 days agoChange DetectedNo significant additions or deletions were detected; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check12 days agoChange DetectedMinor formatting and layout adjustments on the Study Details page for NCT05869955; core study information (title, conditions, eligibility, endpoints, and recruitment status) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check19 days agoChange DetectedThe inclusion criterion was updated to require inadequate response to three or more immunosuppressive therapies (IST), replacing the prior condition of inadequate response to at least one of several listed therapies for at least 3 months.SummaryDifference0.4%
- Check26 days agoChange DetectedUpdated recruitment listings with new affiliations and sites (new institutions and dates), while removing older dates and site identifiers to reflect current postings.SummaryDifference1%
- Check33 days agoChange DetectedNo significant changes detected.SummaryDifference0.2%
- Check41 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference3%
Stay in the know with updates to CC-97540 in Severe SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-97540 in Severe SLE Clinical Trial page.